Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
Annals of the New York Academy of Sciences
|
July 9, 2003
Cellular models to study dopaminergic injury responses
Timothy J Collier, Kathy Steece-Collier, Susan McGuire, et al.
The Journal of Comparative Neurology
|
August 5, 2003
Interference with anoikis-induced cell death of dopamine neurons: implications for augmenting embryonic graft survival in a rat model of Parkinson's disease
Deanna M Marchionini, Timothy J Collier, Maria Camargo, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology
|
December 4, 2009
Increasing CNS noradrenaline reduces EAE severity
Maria Vittoria Simonini, Paul E Polak, Anthony Sharp, et al.
Journal of Neuroimmunology
|
November 6, 2012
The novel HSP90 inhibitor, PU-H71, suppresses glial cell activation but weakly affects clinical signs of EAE
Lucia Lisi, Susan McGuire, Anthony Sharp, et al.
Journal of Neurochemistry
|
February 18, 2005
Identification of complement 5a-like receptor (C5L2) from astrocytes: characterization of anti-inflammatory properties
Vitaliy Gavrilyuk, Sergey Kalinin, Brian S Hilbush, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
Annals of the New York Academy of Sciences
|
July 9, 2003
Cellular models to study dopaminergic injury responses
Timothy J Collier, Kathy Steece-Collier, Susan McGuire, et al.
The Journal of Comparative Neurology
|
August 5, 2003
Interference with anoikis-induced cell death of dopamine neurons: implications for augmenting embryonic graft survival in a rat model of Parkinson's disease
Deanna M Marchionini, Timothy J Collier, Maria Camargo, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology
|
December 4, 2009
Increasing CNS noradrenaline reduces EAE severity
Maria Vittoria Simonini, Paul E Polak, Anthony Sharp, et al.
Journal of Neuroimmunology
|
November 6, 2012
The novel HSP90 inhibitor, PU-H71, suppresses glial cell activation but weakly affects clinical signs of EAE
Lucia Lisi, Susan McGuire, Anthony Sharp, et al.
Journal of Neurochemistry
|
February 18, 2005
Identification of complement 5a-like receptor (C5L2) from astrocytes: characterization of anti-inflammatory properties
Vitaliy Gavrilyuk, Sergey Kalinin, Brian S Hilbush, et al.
Page
of 1